Skip to main content

Table 2 Characteristics of patients with complicated chemotherapy-induced diarrhea who underwent capsule endoscopy

From: Small intestinal mucosal injury and its risk factors in patients with gastrointestinal cancer who developed complicated fluoropyrimidine-induced diarrhea

No

Cancer

PS

Treatment

Cycle

Diarrhea grade

Complicating signs

Neutrophil count*

Wall thickening of small intestine

Schedule time**

Endoscopic findings

Redness

Erosion

Ulcer

1

Gastric

1

Capecitabine

Cisplatin

Trastuzumab

1

2

Cramping, sepsis

4070

+

14

+

+

–

2

Gastric

1

Capecitabine

Cisplatin

Trastuzumab

3

2

sepsis

5330

+

17

+

+

–

3

Gastric

1

S-1

Docetaxel

Cislatin

1

1

Cramping, fever

6600

–

19

+

+

–

4

Gastric

2

S-1

Oxaliplatin

1

3

Cramping fever

3100

N/A

11

+

+

–

5

Gastric

1

S-1

Cisplatin

1

1

Decreased PS fever

2650

+

2

+

+

+

6

Gastric

1

Capecitabine

Oxaliplatin

1

3

Cramping fever

4290

–

9

+

–

–

7

Gastric

1

5-FU

4

3

Cramping

4520

+

8

+

+

+

8

Gastric

1

S-1

Oxaliplatin

1

2

Cramping

3210

–

2

–

–

–

9

Gastric

1

S-1

Cisplatin

5

3

–

6570

–

7

+

–

–

10

Gastric

0

S-1

8

3

Vomiting

2880

–

5

–

–

–

11

Colon

2

5-FU

Oxaliplatin

1

1

Cramping ileus

2990

+

3

+

+

–

12

Colon

1

S-1

Irinotecan

Bevacizumab

1

2

Cramping vomiting

3490

+

13

+

–

–

13

Colon

1

Capecitabine

Oxaliplatin

1

3

Cramping

2170

+

21

+

+

+

  1. PS performance status, 5-FU 5-fluorouracil, N/A not available
  2. *cells/mm3, **Number of days after the end of chemotherapy courses and capsule endoscopy